HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A comparison of protoporphyrin IX and protoporphyrin IX dimethyl ester as a photosensitizer in poorly differentiated human nasopharyngeal carcinoma cells.

Abstract
Protoporphyrin IX dimethyl ester (PME), a dimethyl esterification of protoporphyrin IX (PpIX), exhibits higher intracellular uptake into NPC/CNE2 cells, a poorly differentiated human nasopharyngeal carcinoma, than does PpIX. Phototoxicity studies reveal PME to be a more potent photosensitizer than is PpIX, at the early and late incubation time points. Correlating phototoxicity with subcellular localization indicates that PME is a more potent photosensitizer when its primary target of photodamage is mitochondria. Also, additional targeting of lysosome enhances phototoxicity.
AuthorsKaren Kar Lye Yee, Khee Chee Soo, Boon Huat Bay, Malini Olivo
JournalPhotochemistry and photobiology (Photochem Photobiol) Vol. 76 Issue 6 Pg. 678-82 (Dec 2002) ISSN: 0031-8655 [Print] United States
PMID12511050 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Photosensitizing Agents
  • Protoporphyrins
  • protoporphyrin IX
  • dimethyl protoporphyrin IX
Topics
  • Apoptosis (drug effects)
  • Humans
  • Light
  • Nasopharyngeal Neoplasms (metabolism, pathology)
  • Photochemotherapy
  • Photosensitizing Agents (metabolism, pharmacology)
  • Protoporphyrins (metabolism, pharmacology)
  • Time Factors
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: